The store will not work correctly when cookies are disabled.
N-(6-(isoquinolin-8-yl)pyridazin-3-yl)-4-methylbenzenesulfonamide
ID: ALA4745015
PubChem CID: 162648702
Max Phase: Preclinical
Molecular Formula: C20H16N4O2S
Molecular Weight: 376.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(S(=O)(=O)Nc2ccc(-c3cccc4ccncc34)nn2)cc1
Standard InChI: InChI=1S/C20H16N4O2S/c1-14-5-7-16(8-6-14)27(25,26)24-20-10-9-19(22-23-20)17-4-2-3-15-11-12-21-13-18(15)17/h2-13H,1H3,(H,23,24)
Standard InChI Key: AHIPCGFLKFIEKL-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
41.8914 -10.4914 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.4869 -9.7857 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
41.0779 -10.4888 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.6583 -9.7980 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.6572 -10.6175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3652 -11.0265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0749 -10.6171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0721 -9.7944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3634 -9.3891 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.9511 -11.0259 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2434 -10.6150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5358 -11.0223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5347 -11.8404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7782 -9.3831 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.1936 -9.3778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.9013 -9.7871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.6070 -9.3766 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.6043 -8.5585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8901 -8.1528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1874 -8.5657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.3100 -8.1463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9517 -11.8397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2478 -12.2474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2498 -13.0590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9551 -13.4639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.6598 -13.0513 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.6543 -12.2410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 23 1 0
22 10 1 0
5 10 1 0
8 14 1 0
14 2 1 0
2 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 22 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 376.44 | Molecular Weight (Monoisotopic): 376.0994 | AlogP: 3.80 | #Rotatable Bonds: 4 |
Polar Surface Area: 84.84 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.26 | CX Basic pKa: 4.95 | CX LogP: 2.97 | CX LogD: 2.41 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.59 | Np Likeness Score: -1.54 |
References
1. Kimura H,Suda H,Kassai M,Endo M,Deai Y,Yahata M,Miyajima M,Isobe Y. (2021) N-(6-phenylpyridazin-3-yl)benzenesulfonamides as highly potent, brain-permeable, and orally active kynurenine monooxygenase inhibitors., 33 [PMID:33359168] [10.1016/j.bmcl.2020.127753] |